Hip osteoarthritis Osteoarthritis of the hip
Conditions
Interventions
This study involves a 2-week nutritional intervention in which the participants
will be randomly allocated into an intervention group (HC), receiving daily
supplementation of 15g hydrolysed collagen
Sponsors
Universiteit Maastricht
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: • Written informed consent • With osteoarthritis and due for total hip arthroplasty • >= 60 years old • BMI 18.5-35 kg/m2
Exclusion criteria
Exclusion criteria: • Taking medications known to influence protein metabolism • Collagen allergy • Diabetes mellitus • Alcohol abuse • Surgical intervention in past four weeks • GFR
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The main endpoints of this study are the changes in serum concentrations of biomarkers of collagen metabolism perioperatively and up to two weeks after surgery. These biomarkers represent bone and cartilage synthesis (N-terminal propeptide of type I and type II collagen, respectively: P1NP, P2NP) and breakdown (C-terminal telopeptide of type I and type II collagen, respectively: CTx1, CTx2). | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary endpoints include changes in plasma amino acid concentrations. | — |
Countries
Netherlands
Outcome results
None listed